C20orf160 Antibody (N-term) Blocking peptide
€363.00
In stock
SKU
AC-BP13416a
Background:
The specific function of C20orf160 is not yet known.
Other Names:
Cerebral cavernous malformations 2 protein-like, CCM2-like, CCM2L, C20orf160
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP13416a was selected from the N-term region of C20orf160. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: CCM2L
Gene ID: 140706
Primary Accession: Q9NUG4
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
The specific function of C20orf160 is not yet known.
Other Names:
Cerebral cavernous malformations 2 protein-like, CCM2-like, CCM2L, C20orf160
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP13416a was selected from the N-term region of C20orf160. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: CCM2L
Gene ID: 140706
Primary Accession: Q9NUG4
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review